Y Glipt M 500mg/20mg Tablet ER

This combination is indicated for the management of type 2 diabetes mellitus in adults when diet and exercise alone do not provide adequate glycemic control. The extended-release formulation allows for once-daily dosing, improving patient compliance. Y Glipt M should be used with caution in patients with renal impairment, hepatic dysfunction, or a history of lactic acidosis. Common adverse effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort.

Regular monitoring of blood glucose levels and renal function tests is recommended during therapy. This combination therapy offers a complementary mechanism of action targeting multiple pathophysiological defects in type 2 diabetes, optimizing glycemic control.